Moderna to curb investments in vaccine trials amid health officials' opposition to immunizationsSee details
Moderna - MRNA - stock price prediction, stock price target, analyst ratings from 24 analysts
Moderna has a share price target of US$ 37, revenue growth forecast of -42.3%, and profit growth estimate of 13.8% for FY25, based on top 24 analyst calls.